Two Seas Capital LP - 31 Dec 2024 SCHEDULE 13G Report for Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share (ADAP)

Filing Manager
Two Seas Capital LP
Reporting Manager
Two Seas Capital LP
Security
Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share
Symbol
ADAP
Shares outstanding
1,534,670,276 shares
Disclosed Ownership
89,010,876 shares
Ownership
5.8%
Form type
SCHEDULE 13G
Filing time
14 Feb 2025, 09:31:31 UTC
Date of event
31 Dec 2024
Next filing
15 May 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Two Seas Capital LP 5.8% 89,010,876 89,010,876 0 /s/ Sina Toussi Sina Toussi / Managing Member of Two Seas Capital GP LLC, its General Partner
Two Seas Capital GP LLC 5.8% 89,010,876 89,010,876 0 /s/ Sina Toussi Sina Toussi / Managing Member
Sina Toussi 5.8% 89,010,876 89,010,876 0 /s/ Sina Toussi Sina Toussi / Self